Wegovy commonly causes gastrointestinal adverse effects including nausea, vomiting, diarrhoea, constipation, and abdominal discomfort, especially during dose escalation
Despite this value, access to GLP1s for weight loss remains limited because Medicare and most private insurers do not broadly cover these new treatments
The self-pay pricing through NovoCare at $499 per month for semaglutide, with some doses available at $149 to $199, represents the manufacturer direct-purchase option for patients who do not qualify for other programs
combined Atf5-carrying modRNA with bone-marrow mesenchymal stem-cellderived engineered exosomes to generate Ex modAtf5 , and used an injectable PLGAPEGPLGA hydrogel (Gel) as the carrier to achieve sustained release (Gel@Ex modAtf5 )
If you are not able to lose weight without medication, you may then be put on a waiting list to see a specialist weight management service
Both medications have been rigorously studied and are generally safe when prescribed appropriately